钙调神经磷酸酶
糖尿病肾病
内分泌学
内科学
下调和上调
链脲佐菌素
调节器
化学
糖尿病
生物
细胞生物学
医学
移植
生物化学
基因
作者
Chorong Jang,Ji Hee Lim,Cheol Whee Park,Young-Jin Cho
出处
期刊:The Korean Journal of Physiology and Pharmacology
[The Korean Society of Pharmacology]
日期:2011-10-01
卷期号:15 (5): 299-299
被引量:26
标识
DOI:10.4196/kjpp.2011.15.5.299
摘要
Calcineurin (CaN) is activated in diabetes and plays a role in glomerular hypertrophy and extracellular matrix (ECM) accumulation. Here, kidneys from diabetic model mice were investigated for the expression of the regulator of CaN 1 (RCAN1) isoform 4 (RCAN1.4) which had been shown to be transcriptionally upregulated by CaN activation. We found the increased immunoreactivity for RCAN1 in the glomerular cells of db/db mice and streptozotocin-induced diabetic mice. In concordance, the expression of RCAN1 protein and RCAN1.4 mRNA were elevated in the whole kidney sample from db/db mice. Interleukin-1β (IL-1β), tumor necrosis factor-α, and glycated albumin (AGE-BSA) were identified as inducers of RCAN1.4 in mesangial cells. Pretreatment of cyclosporine A blocked the increases of RCAN1.4 stimulated by IL-1β or AGE-BSA, suggesting that activation of CaN is required for the RCAN1.4 induction. Stable transfection of RCAN1.4 in Mes-13 mesangial cells upregulated several factors relevant to ECM production and degradation. These results suggested that RCAN1.4 might act as a link between CaN activation and ECM turnover in diabetic nephropathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI